-+ 0.00%
-+ 0.00%
-+ 0.00%
Elanco Q3 net income swings to $18 million
Share
Listen to the news
Elanco Q3 net income swings to $18 million
  • Elanco Animal Health swung to third-quarter 2026 net income of $18 million.
  • Revenue rose 11% year-over-year to $1.27 billion.
  • Credelio Quattro received a positive European Medicines Agency opinion for EU expansion, with launch expected in first-quarter 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611060627PR_NEWS_USPR_____DE90686) on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending